Jennifer Fehlman, MD
Dermatology · Saint Louis, MONPI 1134534811
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.1% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by AbbVie at 32.8% of the total. Reporting peaked in 2019 at $441 and has fallen 93.7% since, to $28 in 2025. That places this record below the midpoint for dermatology clinicians in MO, where the typical reported total is $3,173.
Across 26 payments — averaging $30.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$258
- Galderma Laboratories, L.p.$230
- Novartis$86
- Pfizer$70
- Revance Therapeutics, Inc.$54
- Merz North America, Inc.$47
- plus $41 from 3 others
Across 9 payments — averaging $25,984 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$234K
What the payments were for
- Food & beverage$71591%
- Education$709%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 12 | $258 |
| Galderma Laboratories, L.p. | 5 | $230 |
| Novartis | 1 | $86 |
| Pfizer | 2 | $70 |
| Revance Therapeutics, Inc. | 2 | $54 |
| Merz North America, Inc. | 1 | $47 |
| Mission Pharmacal Company | 1 | $16 |
| UCB, Inc. | 1 | $14 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $11 |
How this compares
$784 in reported general payments places this provider in the 20th percentile of 263 dermatology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Ir-DrDoxycycline Monohydrate | 11 | $8,555 |
| Tacrolimus | 13 | $2,530 |
| Doxycycline Hyclate | 44 | $1,007 |
| Metronidazole | 17 | $946 |
| Fluocinonide | 24 | $879 |
| Ketoconazole | 55 | $872 |
| ValacyclovirValacyclovir Hcl | 33 | $556 |
| Clobetasol Propionate | 11 | $302 |
| Triamcinolone Acetonide | 27 | $300 |
| Mupirocin | 12 | $92 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Saint Louis
- Brian KimSaint Louis$861K
- Elaine SiegfriedSaint Louis$856K
- Craig LeonardiSaint Louis$569K
- Mary GeorgeSaint Louis$400K
- Duane DilworthSaint Louis$288K
- Jeffrey ReedSaint Louis$170K
- Emily ColeSaint Louis$163K
- Dee GlaserSaint Louis$131K
- Milan AnadkatSaint Louis$129K
- Jason AmatoSaint Louis$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.